Abstract:In the Discussion section (first paragraph, third sentence) on page 105 of the above-noted article, the sentence “The RNA architectures identified in our study were not predicted by in silico approaches (Pervouchine 2014), nor were they detected using recent high-throughput RNA structure sequencing techniques (Daines et al. 2011; Li et al. 2012)” was not clear and should instead read as follows: “The RNA bidirectional structural architectures identified in our study were not detected using recent high-throughput RNA structure sequencing techniques (Daines et al. 2011; Li et al. 2012), nor were they discovered by in silico approaches, although stem II of the Drosophila srp pre-mRNA was predicted (Raker et al. 2009; Pervouchine 2014).” Accordingly, the following reference should be included in the References section: Raker VA, Mironov AA, Gelfand MS, Pervouchine DD. 2009. Modulation of alternative splicing by long-range RNA structures in Drosophila. Nucleic Acids Res 37: 4533–4544. The authors apologize for any confusion this may have caused. This article has been corrected in both the PDF and full-text HTML files online.

Corrigendum to: Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Corrigendum to “from Phenotype to Gene: Detecting Disease‐specific Gene Functional Modules Via a Text‐based Human Disease Phenotype Network Construction” [FEBS Lett. 584 (2010) 3635–3643]

Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses.

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Erratum for Zhao et al., "Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1"

Corrigendum to “Aptamer-Based Cell-Free Detection System to Detect Target Protein” [synth Syst Biotechnol 6 (3) (2021) 209–215]

Correction: Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2.

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

Corrigendum: Long-range RNA Pairings Contribute to Mutually Exclusive Splicing

Corrigendum to “TREAT: Therapeutic RNAs exploration inspired by artificial intelligence technology” [Comput Struct Biotechnol J 20 (2022) 5680–5689]

Corrigendum to"Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment" [Bioact Mater 24 (2022) 37-53]

Corrigendum: Editorial: the Mechanisms of Action of Anti-Sars-cov-2 Drugs

Corrigendum to “SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip” [Sci. Bull. (2021) 66 (8) 783–793]

Corrigendum: Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System

Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics

Correction to "Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2"